Kadant to replace Inari Medical in S&P 600 at open on 2/19
Written by Emily J. Thompson, Senior Investment Analyst
S&P SmallCap 600 Update: Kadant (KAI) will replace Inari Medical (NARI) in the S&P SmallCap 600 effective February 19, prior to market opening.
Acquisition Details: Inari Medical is being acquired by Stryker (SYK), with the deal expected to close soon, subject to final conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
